Ensure production, adequate stock of methylprednisolone, heparin, dexamethasone: NPPA directs pharma cos Ruchika Sharma10 July 2020 4:49 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has directed State Drug Controllers (SDCs) to...
Sanofi, GSK close to USD 624 million Vaccine supply Deal: Bloomberg Ruchika Sharma6 July 2020 12:00 PM ISTUK: GlaxoSmithKline and Sanofi are close to reaching a 500 million-pound ($624 million) deal to supply the U.K. government with 60 million doses of a...
Sanofi, Regeneron arthritis drug Kevzara fails COVID-19 study Ruchika Sharma4 July 2020 10:00 AM ISTParis: Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400 mg in COVID-19 patients...
Sanofi India to raise awareness about allergies Ruchika Sharma1 July 2020 11:46 AM IST"Therefore, there is a real need for a revolutionary shift in mindset towards allergies. ''AllergyFree'' is our endeavour to raise awareness so that...
Sanofi-GSK COVID-19 vaccine anticipates approval by early 2021 Ruchika Sharma24 Jun 2020 11:15 AM ISTSanofi, which is hosting virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the...
Sanofi-Regeneron Dupixent gets NMPA nod to treat atopic dermatitis Ruchika Sharma22 Jun 2020 10:30 AM ISTThe approval was based on positive data from the global LIBERTY AD clinical trial program that included nearly 3,000 patients with inadequately...
France aims for paracetamol production within three years Ruchika Sharma21 Jun 2020 9:00 AM IST"We are working with (pharmaceutical groups) Seqens, Upsa and Sanofi so that within the next three years France can produce, package and distribute...
Sanofi launches VaxLine to support child vaccination in India during COVID Ruchika Sharma18 Jun 2020 11:46 AM ISTVaxLine is a tele-counselling facility with a toll-free number 1800 123 5011 that registers a parent’s missed call and allows a VaxLine health expert...
Sanofi to present growth opportunities, development strategy for Dupixent in type 2 inflammatory diseases Ruchika Sharma14 Jun 2020 9:15 AM ISTAs announced in December 2019, Sanofi expects to deliver strong growth for Dupixent with the ambition of achieving more than €10 billion in peak sales...
Biocon, Mylan get USFDA approval for insulin glargine injection Semglee Ruchika Sharma12 Jun 2020 1:17 PM ISTSemglee has an identical amino acid sequence to Sanofi's Lantus® and is approved for the same indications
Sanofi to present Phase 3 results of avalglucosidase alfa in late-onset Pompe disease patients Ruchika Sharma10 Jun 2020 9:15 AM ISTThe U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to avalglucosidase alfa for the treatment of patients...
Sanofi Multiple Myeloma Drug Sarclisa Gets European Nod Ruchika Sharma5 Jun 2020 9:30 AM ISTSarclisa is a monoclonal antibody (mAb) that binds to a specific epitope on the CD38 receptor of MM cells
